News | EP Lab | August 03, 2021

Biosense Webster Showcases New Data and Latest Innovations at Heart Rhythm 2021

Late-breaking results from first-in-human clinical experience of NuVision 4D ICE Ultrasound Catheter presented

The new Octaray high-density mapping catheter from Biosense Webster has 48 electrodes to enable faster and more detailed electromapping of the heart to better guide ablation procedures.

The new Octaray high-density mapping catheter from Biosense Webster has 48 electrodes to enable faster and more detailed electromapping of the heart to better guide ablation procedures. Photo by Dave Fornell


August 3, 2021 – Biosense Webster, the global leader in cardiac arrhythmia treatment and part of Johnson & Johnson Medical Devices Companies, announced today that data from 16 company sponsored studies will be presented at Heart Rhythm 2021, the Heart Rhythm Society (HRS) annual meeting. The data presented reflects Biosense Webster’s continued innovation and commitment to advancing science in the field of electrophysiology with the goal of improving patient outcomes.

Presentation topics included new data on novel technologies spanning Carto mapping technology, diagnostic catheters, therapeutic catheters, and the role of digital technologies in advancing cardiac arrhythmia treatment. Additionally, two abstracts will be presented highlighting real-world data on atrial fibrillation treatment outcomes.

As part of the Biosense Webster booth, a variety of interactive experiences will be available including hands-on demonstrations of the new Octaray high density mapping catheter with TRUEref Technology, CartoNet cloud-based software solution, and NuVision Ultrasound Catheter with imaging support from GE Healthcare Vivid Ultra Edition ultrasound systems.

For more information about Biosense Webster’s presence at Heart Rhythm 2021: www.BiosenseWebsterHRS.com

For more information: www.biosensewebster.com

VIDEO: EP Trends and New Technology From Biosense Webster at HRS 2021

Related Content

News | EP Lab

May 24, 2022 — Attune Medical, a pioneering medical device company with a technology platform based on temperature ...

Home May 24, 2022
Home
News | EP Lab

May 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home May 04, 2022
Home
News | EP Lab

April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home April 27, 2022
Home
News | EP Lab

Royal Philips, a global leader in health technology, announced late-breaking results of a large-scale, real-world ...

Home April 12, 2022
Home
News | EP Lab

January 14, 2022 — Medtronic has entered into a definitive agreement to acquire Affera Inc., a Boston area-based ...

Home January 14, 2022
Home
News | EP Lab

January 13, 2022 — Abbott received U.S. Food and Drug Administration (FDA) clearance for the EnSite X EP System with ...

Home January 13, 2022
Home
News | EP Lab

January 7, 2022 — Khaldoun Tarakji, M.D., M.P.H., associate section head of cardiac electrophysiology at the Heart ...

Home January 07, 2022
Home
News | EP Lab

January 5, 2022 — Stereotaxis announced a recent publication in Frontiers in Cardiovascular Medicine titled “Atrial ...

Home January 05, 2022
Home
Feature | EP Lab

Children’s Hospital Los Angeles cardiologist Michael Silka, M.D., helped to pioneer the development of indications for ...

Home December 07, 2021
Home
News | EP Lab

November 22, 2021 — BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical ...

Home November 22, 2021
Home
Subscribe Now